FDAnews
www.fdanews.com/articles/84547-th-group-unit-to-invest-rm7-5m-in-alpha-biologics

TH GROUP UNIT TO INVEST RM7.5M IN ALPHA BIOLOGICS

February 14, 2006

TH Group Bhd's subsidiary, Asiaprise Biotech Sdn Bhd, will invest RM7.5 million in biotechnology company Alpha Biologics Sdn Bhd through the subscription of a 39.47% stake comprising 7.5 million shares of RM1 each. Asiaprise yesterday entered an investment and shareholders agreement with Alpha Biologics and its parent company, Spring Hill Bioventures Sdn Bhd, to further extend its business reach in the biotechnology sector by playing a key role in contract biomanufacturing organisation (CMO) industry in this region.

The Edge Daily (http://www.theedgedaily.com/cms/content.jsp?id=com.tms.cms.article.Article_633df2d7-cb73c03a-1e807610-954d9f09)

(http://www.bloomberg.com/apps/news?pid=10000102&sid=aYW4iYmkPTMc&refer=uk)